Cocrystal Pharma, Inc. — Director's Dealing 2015

Oct 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2015-10-01

Reporting Person: Mayers Douglas L (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-01	Stock Options (Right to buy)	$0.70	A	2400000	Acquired	2025-10-01	Common Stock (2400000)	Direct

Footnotes

F1: The Securities vest in four equal annual increments with the first vesting date being one year from the Transaction Date.

F2: Not applicable